英派药业-B香港首秀:开盘价定为每股35.5港元,较发行价20.10港元大幅溢价

美股速递
May 13

英派药业-B(股票代码:07630)即将在香港交易所迎来其首日交易,市场瞩目的开盘价已定为每股35.5港元。这一价格显著高于其每股20.10港元的首次公开募股(IPO)发行价,预示着该生物科技公司获得了资本市场的热烈追捧。

开盘价与发行价之间高达76.6%的溢价空间,直观地反映了投资者对英派药业-B发展前景的强烈信心。在生物医药板块持续受到关注的背景下,公司此次上市表现无疑成为市场焦点。强劲的认购需求和积极的定价,为公司在公开市场的亮相奠定了坚实的基础,也为后续交易日的走势提供了重要的初始动能。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10